Gardasil Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
Conditions:   Immunization;   Efficacy;   Human Papilloma Virus Interventions:   Biological: 9-valent HPV vaccine, 2 dose efficacy;   Biological: 9-valent HPV vaccine, 3 doses standard timing Sponsors:   The University of Texas Medical Branch, Galveston;   Cancer Prevention Research Institute of Texas Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2019 Category: Research Source Type: clinical trials